SINOMED(688108)2024-11-13 10:08Group 1: Company Overview - Sino Medical Science and Technology Co., Ltd. is listed under stock code 688108 and is referred to as Sino Medical [1] - The investor relations activity took place on November 13, 2024, from 13:00 to 14:00 [1] Group 2: Performance and Market Strategy - The company is addressing investor concerns regarding its operational performance for the first three quarters of 2024 [1] - The introduction of the "3+N" procurement policy in Hebei has affected the market entry speed of the company's products, particularly the Spinal Balloon [2] - The company is actively pursuing both the implementation of procurement policies and expanding its non-procurement market to enhance sales [2] Group 3: Financial Growth and Future Prospects - The company has a diverse product range in coronary and neuro intervention, with over 20 products contributing to its revenue [2] - Ongoing research and commercialization of multiple products are expected to contribute to future revenue growth [2] - Continuous technical improvements and cost reduction measures are anticipated to enhance product gross margins [2] Group 4: Investor Engagement - The chairman expressed gratitude for investor participation and feedback during the earnings presentation [3] - The company aims to strengthen investor understanding and support through effective communication [3]